Sub-Result 4 Sample Clauses

Sub-Result 4. 2: Evidence of what works in PMCD informed by results from program learning and iterative adaptation 61
AutoNDA by SimpleDocs
Sub-Result 4. 3: Evidence utilized to inform programming and policy with local and global stakeholders Publication: One research article was published on GHSP, title “Improving Contraceptive Access, Use, and Method Mix by Task Sharing Implanon Insertion to Frontline Health Workers: The Experience of the Integrated Family Health Program in Ethiopia”. Oral and poster conference presentation: Two research abstracts submitted to the 29th EPHA annual conference held in Addis Ababa, on February 2018. Family Planning and Reproductive health: The Project FP/RH team is a member of the FP technical working groups at different levels. During this quarter, the project participated in the updating of the national reproductive health guideline and in a special working group organized by the FMOH to prepare a guide for level-IV HEWs program on comprehensive FP trainings. Similarly, the regional project office FP/RH teams participated in the regional FP TWG, and consultative meetings with partners and regional health offices. Accordingly, in Amhara region discussion were held with Engender Health and Ipas to avoid duplication of efforts, and reached on mutual agreement, that the Transform: Primary Health Care Project will retain 49 woredas while 27 woredas were transferred to Engender Health (20 woredas) and Ipas (7 woredas) as FP/RH interventions woredas. Adolescent and Youth Health and Development (AYHD): The adolescent and Youth thematic area is an active member of the national Adolescent and Youth working group (TWG) that was organized by FMOH. The AYHD team members played an active role in the national and regional level technical working group to improve the quality of the service rendered and scale up of the adolescent and youth services at all level.
Sub-Result 4. 2: Evidence of what works in EPCMD informed by results from program learning and iterative adaptation Effectiveness assessment of BINLM based training- As a new national initiative of its kind; the project has studied Blended Integrated Nutrition Learning Material (BINLM) based trainings. The purpose was to explore issues related to the approach with a qualitative investigation using key informant interview. This has provided a good insight in to the issues around the approach. Quantitative study was also done to measure effectiveness of the method in ‘knowledge acquisition’. A paper is produced and was used for advocacy with FMOH and helped to get a buy-in to urgently improve the critical issues in the material. Making case for Calcium supplementation for Pregnant Women in Ethiopia- An advocacy paper was prepared by analyzing evidence on the importance of calcium supplementation for pregnant women in Ethiopia where calcium intake is very low in all regions. Evidence indicate that the intervention can significantly reduce the risk of hypertensive disease of pregnancy which is the second top killer in Ethiopia. The findings were discussed with the FMOH. The cost of the intervention and its scalability are now the limiting factors to consider before piloting. We are currently looking for low cost options. Health Care Financing (HCF) specific checklists prepared. The HCF thematic area checklists were field piloted to assess the clarity, completeness, and adequacy of the lists, and to make any needed adjustments prior to use. The checklists are to be used for data collection, mentoring, coaching and onsite technical support activities. The pilot took place at health facilities in the four project target regions. Modifications to the checklist were made based on issues identified during the pilot. Thus, two separate checklists (one was for primary hospital and the other was for health centers) were merged into one checklist and the list of questions was reduced. The final checklist was aligned with the existing government initiatives like the Ethiopia Hospital Transformation Guideline (EHTG), the Ethiopian Health Center Reform Implementation Guideline (EHCRIG) and RHB ISS tools. The HCF thematic checklist is separate from the Transform: PHC follow-up visit (FUV) checklist but is complementary in that it collects detailed information that is not covered by the FUV checklist, including detail information on revenue generation, allocation and utilization. The focu...

Related to Sub-Result 4

  • Discussion of Differences If a difference arises between the Employer and an employee(s) or between the Employer and the Union concerning the interpretation, application, operation or any alleged violation of the Agreement, the employee(s) shall continue to work in accordance with the Agreement until the difference is settled.

  • Absence of Defaults and Conflicts Resulting from Transaction The execution, delivery and performance of this Agreement, and the sale of the Securities, will not result in a breach or violation of any of the terms and provisions of, or constitute a default or a Debt Repayment Triggering Event (as defined below) under, or result in the imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, (A) the charter, by-laws or similar organizational documents of the Company or any of its subsidiaries, (B) any statute, rule, regulation or order of any governmental agency or body or any court, domestic or foreign, having jurisdiction over the Company or any of its subsidiaries or any of their properties, or (C) any agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the properties of the Company or any of its subsidiaries is subject except, in the case of clauses (B) and (C) above, any breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; a “Debt Repayment Triggering Event” means any event or condition that gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture, or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries.

  • Conflict of Interest Questionnaire - Form CIQ No response Do not upload this form unless you have a reportable conflict with TIPS. There is an Attribute entitled “Conflict of Interest Questionnaire Requirement” immediately followed by an Attribute entitled “Conflict of Interest Questionnaire Requirement – Form CIQ – Continued.” Properly respond to those Attributes and only upload this form if applicable/instructed. If upload is required based on your response to those Attributes, the Conflict of Interest Questionnaire – Form CIQ must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed, and uploaded at this location.

  • Conflict of Interest Questionnaire Requirement - Form CIQ - Continued If you responded "No, Vendor does not certify - VENDOR HAS CONFLICT" to the Conflict of Interest Questionnaire question above, you are required by law to fully execute and upload the form attachment entitled "Conflict of Interest Questionnaire - Form CIQ." If you accurately claimed no conflict above, you may disregard the form attachment entitled "Conflict of Interest Questionnaire - Form CIQ." Have you uploaded this form if applicable? Not Applicable

  • Recurring Transactions If you intend to use the Card for recurring transactions, you should monitor your balance and ensure you have funds available in your Card Account to cover the transactions. “Recurring Transactions” are transactions that are authorized in advance by you to be charged to your Card at substantially regular intervals. If these Recurring Transactions may vary in amount, the person you are going to pay should tell you, 10 days before each payment, when it will be made and how much it will be. (You may choose instead to get this notice only when the payment would differ by more than a certain amount from the previous payment, or when the amount would fall outside certain limits that you set.) If you have told us in advance to make Recurring Transactions from your Card Account, you can stop the payment by calling us at 0-000-000-0000 or writing us at 0000 X. Xxxxxxxxxx Xxxxx, Xxxx# 000, Xxxxx Xxxxxx, XX 00000xx time for us to receive your request at least three (3) business days before the scheduled date of the payment. If you call, we also may require you to put your request in writing and get it to us within fourteen (14) days after you call. If you order us to stop one of these payments three (3) business days or more before the transfer is scheduled, and we do not do so, we may be liable for your losses or damages. If you have authorized a merchant to make the recurring payment, you should also contact the applicable merchant in order to stop the transaction.

  • Illegal Transactions You agree that your Card and account will not be used to make or facilitate any illegal transactions as determined by applicable law; and that any such use will constitute an event of default under this Agreement. We may decline any transaction that we believe to be illegal under applicable law, including but not limited to any transaction involving or relating to any gambling activity. You agree that we will have no liability or responsibility for any such use by you or any authorized user(s); or for declining any such transaction. You further agree to indemnify and hold us harmless from any suits, liability, damages or adverse action of any kind that results directly or indirectly from such illegal use. You promise to pay us any and all amounts owing on your Card for any transactions made by you, even if the transaction is determined to be illegal.

  • Withdrawal of Property from Market or Termination of Discussions Potential Investor acknowledges that the Property has been offered for sale subject to withdrawal of the Property from the market at any time or rejection of any offer because of the terms thereof, or for any other reason whatsoever, without notice, as well as the termination of discussions with any party at any time without notice for any reason whatsoever.

  • Effective Date of Transfer Any assignment of a Limited Partner's Interest or Special Limited Partner's Interest pursuant to Section 12.1 shall become effective as of the first day of the calendar month in which the last of the conditions to such assignment are satisfied.

  • Upset Date If the Closing shall not have occurred on or before December 31, 1997.

  • Fundamental Transactions If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company with or into another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”), (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iv) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock) (in any such case, a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of shares of Common Stock of the Successor Entity or of the Company and any additional consideration (the “Alternate Consideration”) receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise such warrant into Alternate Consideration.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!